JP2022527381A5 - - Google Patents

Info

Publication number
JP2022527381A5
JP2022527381A5 JP2021559527A JP2021559527A JP2022527381A5 JP 2022527381 A5 JP2022527381 A5 JP 2022527381A5 JP 2021559527 A JP2021559527 A JP 2021559527A JP 2021559527 A JP2021559527 A JP 2021559527A JP 2022527381 A5 JP2022527381 A5 JP 2022527381A5
Authority
JP
Japan
Prior art keywords
amino acid
sequences
antigen
value
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559527A
Other languages
English (en)
Japanese (ja)
Other versions
JP7524215B2 (ja
JP2022527381A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/053370 external-priority patent/WO2020208555A1/en
Publication of JP2022527381A publication Critical patent/JP2022527381A/ja
Publication of JP2022527381A5 publication Critical patent/JP2022527381A5/ja
Application granted granted Critical
Publication of JP7524215B2 publication Critical patent/JP7524215B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559527A 2019-04-09 2020-04-08 抗体を分類するためのシステムおよび方法 Active JP7524215B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962831663P 2019-04-09 2019-04-09
US62/831,663 2019-04-09
PCT/IB2020/053370 WO2020208555A1 (en) 2019-04-09 2020-04-08 Systems and methods to classify antibodies

Publications (3)

Publication Number Publication Date
JP2022527381A JP2022527381A (ja) 2022-06-01
JP2022527381A5 true JP2022527381A5 (https=) 2023-03-28
JP7524215B2 JP7524215B2 (ja) 2024-07-29

Family

ID=70293015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021559527A Active JP7524215B2 (ja) 2019-04-09 2020-04-08 抗体を分類するためのシステムおよび方法

Country Status (8)

Country Link
US (1) US20220157403A1 (https=)
EP (1) EP3953943A1 (https=)
JP (1) JP7524215B2 (https=)
CN (1) CN113853656A (https=)
AU (2) AU2020271361A1 (https=)
CA (1) CA3132189A1 (https=)
IL (1) IL287025A (https=)
WO (1) WO2020208555A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11049590B1 (en) 2020-02-12 2021-06-29 Peptilogics, Inc. Artificial intelligence engine architecture for generating candidate drugs
US11403316B2 (en) 2020-11-23 2022-08-02 Peptilogics, Inc. Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates
US11512345B1 (en) 2021-05-07 2022-11-29 Peptilogics, Inc. Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids
WO2022245737A1 (en) * 2021-05-17 2022-11-24 Genentech, Inc. Function guided in silico protein design
WO2022248935A1 (en) * 2021-05-27 2022-12-01 Lynceus Sas Machine learning-based quality control of a culture for bioproduction
US11567488B2 (en) * 2021-05-27 2023-01-31 Lynceus, Sas Machine learning-based quality control of a culture for bioproduction
WO2022271636A1 (en) * 2021-06-22 2022-12-29 Evqlv, Inc. Computational characterization and selection of sequence variants
WO2023036849A1 (en) * 2021-09-07 2023-03-16 ETH Zürich Identifying and predicting future coronavirus variants
WO2023049466A2 (en) * 2021-09-27 2023-03-30 Marwell Bio Inc. Machine learning for designing antibodies and nanobodies in-silico
IL312409A (en) * 2021-11-01 2024-06-01 Adimab Llc Systems and methods for intelligent construction of antibody libraries
US20230268026A1 (en) * 2022-01-07 2023-08-24 Absci Corporation Designing biomolecule sequence variants with pre-specified attributes
CN115116543B (zh) * 2022-04-18 2025-08-05 腾讯科技(深圳)有限公司 抗原抗体结合位点确定方法、装置、设备和存储介质
WO2023215322A1 (en) * 2022-05-02 2023-11-09 Merck Sharp & Dohme Llc Generative modeling leveraging deep learning for antibody affinity tuning
US12306862B2 (en) * 2022-05-13 2025-05-20 S&P Global Inc. Information extraction for unstructured text documents
CN115171774A (zh) * 2022-05-17 2022-10-11 慧壹科技(上海)有限公司 一种抗体/大分子药物的亲和力改造系统和方法
WO2023246834A1 (en) * 2022-06-24 2023-12-28 King Abdullah University Of Science And Technology Reinforcement learning (rl) for protein design
WO2024040020A1 (en) * 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
CN117672351A (zh) * 2022-09-01 2024-03-08 珠海碳云智能科技有限公司 一种评估抗体与多肽芯片结合特征的方法
WO2024051806A1 (zh) * 2022-09-09 2024-03-14 南京金斯瑞生物科技有限公司 一种设计人源化抗体序列的方法
EP4668279A4 (en) 2023-02-16 2026-03-25 Fujitsu Ltd INFORMATION PROCESSING PROGRAM, INFORMATION PROCESS, AND INFORMATION PROCESSING DEVICE
US12587274B2 (en) 2023-03-28 2026-03-24 Quantum Generative Materials Llc Satellite optimization management system based on natural language input and artificial intelligence
WO2024208261A1 (zh) * 2023-04-04 2024-10-10 南京金斯瑞生物科技有限公司 用于抗体药物开发的黏度预测方法
US12531162B1 (en) * 2023-05-31 2026-01-20 Northeastern University Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net
WO2025070104A1 (ja) * 2023-09-28 2025-04-03 富士フイルム株式会社 情報処理装置、情報処理装置の作動方法、および情報処理装置の作動プログラム
CN117594114B (zh) * 2023-10-30 2024-12-03 康复大学(筹) 一种基于蛋白质结构域预测与生物大分子修饰结合的类抗体的方法
US12562256B2 (en) * 2023-11-07 2026-02-24 New York University Systems, methods and computer-accessible medium for identifying target pairs for CAR-T therapy
WO2025128525A1 (en) * 2023-12-11 2025-06-19 Research Development Foundation System and method for predicting microproteins
US12603701B2 (en) 2023-12-27 2026-04-14 Quantum Generative Materials Llc Distributed satellite constellation management and control system
US12368503B2 (en) 2023-12-27 2025-07-22 Quantum Generative Materials Llc Intent-based satellite transmit management based on preexisting historical location and machine learning
US20250279158A1 (en) * 2024-02-29 2025-09-04 Lurong Pan Computer-assisted method and system for evaluating and modifying immunogenicity of protein sequences using a protein large language model
WO2025235938A1 (en) * 2024-05-10 2025-11-13 Regeneron Pharmaceuticals, Inc. Computational methods and systems for predicting developability of protein sequences

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099999A2 (en) * 2002-05-20 2003-12-04 Abmaxis, Inc. Generation and selection of protein library in silico
WO2014180490A1 (en) * 2013-05-10 2014-11-13 Biontech Ag Predicting immunogenicity of t cell epitopes
JP2019513415A (ja) 2016-04-04 2019-05-30 イーティーエッチ チューリッヒ タンパク質産生及びライブラリー生成のための哺乳類細胞株
GB201607521D0 (en) * 2016-04-29 2016-06-15 Oncolmmunity As Method
WO2018132752A1 (en) * 2017-01-13 2018-07-19 Massachusetts Institute Of Technology Machine learning based antibody design
CN109036580B (zh) 2018-07-06 2021-08-20 华东师范大学 基于相互作用能项和机器学习的蛋白-配体亲和力预测方法

Similar Documents

Publication Publication Date Title
JP2022527381A5 (https=)
JP7524215B2 (ja) 抗体を分類するためのシステムおよび方法
RU2540150C2 (ru) Способы модификации антител и модифицированные антитела с улучшенными функциональными свойствами
CN101688200B (zh) 单链抗体的基于序列的改造和优化
JP2022530941A5 (https=)
JP7695881B2 (ja) 操作されたcd25ポリペプチドおよびその使用
EP3982369A1 (en) Information processing system, information processing method, program, and method for producing antigen-binding molecule or protein
CN109415441B (zh) 抗体及其制备方法
US20200066372A1 (en) Method for improving antibody stability
Gallo The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design
CN117024585A (zh) 抗甲状腺球蛋白单克隆抗体及其应用
CN119019561A (zh) 提升抗体对于抗原的亲和性的方法及其利用
Huo et al. Computational nanobody design through deep generative modeling and epitope landscape profiling
CN116462763A (zh) 一种结合抗her2抗体的抗体或其结合片段及其应用
CN116003615B (zh) 一种抗卡利普多的单克隆抗体及其应用
CN118791608B (zh) 一种抗igf-1抗体及其抗原结合片段
US20230417753A1 (en) Methods and kits for classifying solid cancer-afflicted patients based on relb labelling
WO2025219231A1 (en) Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
Paul Modelling Sequence and Structure Towards Functional Protein Design
WO2023036849A1 (en) Identifying and predicting future coronavirus variants
CN119751669A (zh) 一种p-Tau217抗体及其人源化改造和应用
HK1223684B (en) Method for improving antibody stability
HK40063514A (en) Engineered cd25 polypeptides and uses thereof
Kelly Determinants of antibody specificity